Cart
sales@molnova.com
3-Hydroxypropionic Acid sodium salt
CAS No. 6487-38-3
3-Hydroxypropionic Acid sodium salt( —— )
Catalog No. M34821 CAS No. 6487-38-3
3-Hydroxypropionic Acid sodium salt can be used to synthesize some degradable plastics and produce a series of C3 compounds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 41 | In Stock |
|
| 10MG | 59 | In Stock |
|
| 25MG | 93 | In Stock |
|
| 50MG | 138 | In Stock |
|
| 100MG | 203 | In Stock |
|
| 200MG | 304 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Hydroxypropionic Acid sodium salt
-
NoteResearch use only, not for human use.
-
Brief Description3-Hydroxypropionic Acid sodium salt can be used to synthesize some degradable plastics and produce a series of C3 compounds.
-
Description3-Hydroxypropionic Acid sodium salt can be used to synthesize some degradable plastics and produce a series of C3 compounds.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6487-38-3
-
Formula Weight112.06
-
Molecular FormulaC3H5NaO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(CCO)[O-].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
NH2-C5-NH-Boc
NH2-C5-NH-Boc (PROTAC Linker 23) is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Bonducellin
Bonducellin has anti-inflammatory activities, it can significantly and dose-dependently inhibit the inflammatory mediators; nitric oxide (NO), and cytokines [tumor necrosis factor (TNF)-alpha and interleukin (IL)-12.
-
cAMP-Dependent Prote...
PKI(5-22)amide is the active inhibitory fragment of the inhibitor of the cyclic AMP-dependent protein kinase (PKA). PKI(5-22)amide inhibits PKA activation, but fails to attenuate homologous desensitization of CRF1 receptors.
